Quantbot Technologies’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $112K | Buy |
+1,369
| New | +$98.9K | ﹤0.01% | 1436 |
|
|
2026
Q1 | – | Sell |
-221
| Closed | -$16.8K | – | 2079 |
|
|
2025
Q4 | $16.8K | Sell |
221
-878
| -80% | -$63.8K | ﹤0.01% | 1572 |
|
|
2025
Q3 | $67.4K | Sell |
1,099
-1,379
| -56% | -$71.8K | ﹤0.01% | 1482 |
|
|
2025
Q2 | $121K | Buy |
2,478
+1,826
| +280% | +$86.7K | ﹤0.01% | 1363 |
|
|
2025
Q1 | $33.2K | Buy |
652
+551
| +546% | +$27.5K | ﹤0.01% | 1348 |
|
|
2024
Q4 | $4.56K | Buy |
+101
| New | +$4.32K | ﹤0.01% | 1398 |
|
|
2024
Q2 | – | Sell |
-5,500
| Closed | -$160K | – | 1819 |
|
|
2024
Q1 | $160K | Buy |
+5,500
| New | +$154K | 0.01% | 1066 |
|
|
2022
Q4 | – | Sell |
-200
| Closed | -$10K | – | 2024 |
|
|
2022
Q3 | $10K | Buy |
+200
| New | +$9.8K | ﹤0.01% | 1425 |
|
|
2021
Q1 | – | Sell |
-246
| Closed | -$15K | – | 1698 |
|
|
2020
Q4 | $15K | Buy |
246
+226
| +1,130% | +$13.3K | ﹤0.01% | 1053 |
|
|
2020
Q3 | $0 | Buy |
+20
| New | +$985 | ﹤0.01% | 1573 |
|
|
2020
Q1 | – | Sell |
-146
| Closed | -$7K | – | 1287 |
|
|
2019
Q4 | $7K | Buy |
+146
| New | +$6.2K | ﹤0.01% | 1126 |
|
|
2018
Q4 | – | Sell |
-2,729
| Closed | -$128K | – | 1333 |
|
|
2018
Q3 | $128K | Buy |
2,729
+2,448
| +871% | +$101K | 0.01% | 825 |
|
|
2018
Q2 | $9K | Buy |
+281
| New | +$8.76K | ﹤0.01% | 1110 |
|
|
2018
Q1 | – | Sell |
-1,067
| Closed | -$17K | – | 1466 |
|
|
2017
Q4 | $17K | Sell |
1,067
-6,435
| -86% | -$109K | ﹤0.01% | 1077 |
|
|
2017
Q3 | $150K | Buy |
+7,502
| New | +$147K | 0.01% | 758 |
|
|
2017
Q1 | – | Sell |
-6,538
| Closed | -$71K | – | 1370 |
|
|
2016
Q4 | $71K | Buy |
+6,538
| New | +$68.6K | 0.01% | 772 |
|
|
2016
Q1 | – | Sell |
-490
| Closed | -$15K | – | 1352 |
|
|
2015
Q4 | $15K | Sell |
490
-1,310
| -73% | -$38.6K | ﹤0.01% | 955 |
|
|
2015
Q3 | $48K | Buy |
+1,800
| New | +$77K | 0.01% | 918 |
|
|
2015
Q2 | – | Sell |
-1,600
| Closed | -$97K | – | 1321 |
|
|
2015
Q1 | $97K | Sell |
1,600
-657
| -29% | -$40.1K | 0.02% | 618 |
|
|
2014
Q4 | $116K | Sell |
2,257
-2,242
| -50% | -$98.7K | 0.04% | 597 |
|
|
2014
Q3 | $198K | Buy |
+4,499
| New | +$141K | 0.03% | 701 |
|
Other funds holding PTCT
RI
JT
Quantbot Technologies's PTCT Position: Q2 2026 in Review
Quantbot Technologies opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 1,369 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #1436 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in PTCT as recently as Q4 2025.
Quantbot Technologies first reported a position in PTCT in Q3 2014 and has held it in 21 quarters since. The position peaked at $198K in Q3 2014. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Quantbot Technologies held 1,369 shares of PTC Therapeutics worth $112K as of Q2 2026.
- PTC Therapeutics was a new Quantbot Technologies position in Q2 2026.
- PTC Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1436 holding.
- Quantbot Technologies first reported a position in PTC Therapeutics in Q3 2014 and has held it in 21 quarters since.
- Quantbot Technologies's PTC Therapeutics position peaked at $198K in Q3 2014.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.